Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01936493 · ClinicalTrials.gov registry record
Biologic Predictors of Leiomyoma Treatment Outcomes
A clinical trial of Uterine Fibroids and Fibroids, sponsored by Elizabeth A. Stewart.
- Completed
- Registry status
- 38
- Enrollment target
- 1
- Study location
NCT01936493 is a study of Uterine Fibroids and Fibroids that has completed, run by Elizabeth A. Stewart. The registered enrollment target is 38 participants, below the 240-participant average among 10 other Uterine Fibroids trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01936493, a study of Uterine Fibroids and Fibroids, has completed, sponsored by Elizabeth A. Stewart.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to search for the hereditary (genetic) causes of uterine fibroids. Some women with uterine fibroids may have one or more genes that make them more likely to develop uterine fibroids. We are trying to identify these genes to better understand how and why uterine fibroids develop and to design better treatment options for women with uterine fibroids. This information may also help us to understand and treat other problems that may be caused by these genes.
Conditions Studied
Interventions
- GENETIC DNA analysis
- OTHER Hormonal analysis
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2009-08 |
| Est. Completion | 2015-05-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01936493
The ClinicalTrials.gov registry entry for NCT01936493 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 240-participant average among 10 other Uterine Fibroids trials with a reported enrollment target (84% lower). The listed sponsor is Elizabeth A. Stewart, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Uterine Fibroids appearing as the primary indexed condition, and to 2 interventions - of which DNA analysis is the first listed.
NCT01936493 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01936493 about?
NCT01936493 is a clinical study titled "Biologic Predictors of Leiomyoma Treatment Outcomes". The purpose of this study is to search for the hereditary (genetic) causes of uterine fibroids. Some women with uterine fibroids may have one or more genes that make them more likely to develop uterine fibroids. We are trying to identify these genes to better understand how and why uterine fibroids ...
What is the current status of trial NCT01936493?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2009-08. Estimated completion is 2015-05-26.
What conditions does trial NCT01936493 study?
This clinical trial studies the following conditions: Uterine Fibroids, Fibroids, Uterine Leiomyomas, Myomas.
What interventions are being tested in trial NCT01936493?
The interventions under investigation include: DNA analysis (GENETIC), Hormonal analysis (OTHER).
Who is sponsoring clinical trial NCT01936493?
This trial is sponsored by Elizabeth A. Stewart, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01936493 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Fibroids
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
RECRUITING · NA
-
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
RECRUITING · Phase 3
-
Effect of Addition of Steroids on Duration of Analgesia
ACTIVE NOT RECRUITING · Early Phase 1
-
Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry
ACTIVE NOT RECRUITING
-
Uterine Leiomyoma Treatment With Radiofrequency Ablation
COMPLETED · NA
-
Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.